Severe infection due to Actinomyces bernardiae: Case report

Clinical Infectious Diseases

Volumn 22, Issue 1, 1996, Pages 157-158

  Ieven, M ^a   Verhoeven, J ^a   Gentens, P ^a   Goossens, H ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFALOTIN; CIPROFLOXACIN; PENICILLIN G;

ACTINOMYCES; ACTINOMYCETALES; AGED; ANTIBIOTIC SENSITIVITY; ARCANOBACTERIUM PYOGENES; ARTICLE; BLADDER DYSFUNCTION; CASE REPORT; CONTROLLED STUDY; HUMAN; HYDROURETER; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; NEPHROLITHIASIS; PERIRENAL ABSCESS; PRIORITY JOURNAL; SEPTICEMIA; URINARY TRACT INFECTION;

EID: 0030034676     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.1.157     Document Type: Article

References (4)

1. Coyle MB, Lipsky BA. Coryneform bacteria in infectious diseases: clinical and laboratory aspects. Clin Microbiol Rev 1990;3:227-46.
2. Na'was TE, Hollis DG, Moss CW, Weaver RE. Comparison of biochemical, morphologic and chemical characteristics of Centers for Disease Control fermentative coryneform groups 1, 2 and A-4. J Clin Microbiol 1987;25:1354-8.
3. Funke G, Ramos CP, Fernandez-Garayzabal JF, Weiss N, Collins MD. Description of human-derived Centers for Disease Control coryneform group 2 bacteria as Actinomyces bernardiae sp. nov. Int J Syst Bacteriol 1995;45:57-60.
4. Soriano F, Pionte C, Santamaria M, Castilla C, Rotlas RF. In vitro and in vivo study of stone formation of Corynebacterium Group 2 (Corynebacterium urealyticum). J Clin Microbiol 1986;23:691-4.